Article Listing - FAVORABLE FORECASTS FOR US BIOTECH

FURTHER WELLCOME SHARE SELL-OFF

9 March 1992

Six years after the first share floatation in UK drugmaker Wellcome, the Wellcome Trust has revealed that a further tranche...

INNOTHERA SEEKING DEVELOPMENT CASH

9 March 1992

The French drug manufacturer, Innothera, which specializes in products for women's diseases, says it is ready to open its capital...

BULLETIN REVIEWS NEW TOPICAL PRODUCTS

9 March 1992

Leo Laboratories' Dovonex (calcipotriol) represents an interesting and useful addition to the menu of treatments available for chronic plaque psoriasis,...

UK DTP VACCINATION SCHEDULE

9 March 1992

New findings released by a team of UK clinicians, under the direction of Robert Booy of the Radcliffe Hospital, Oxford,...

MMD'S 5HT3 RECEPTOR ANTAGONIST

9 March 1992

The pharmacokinetic properties of a new anti-emetic 5-HT3 receptor antagonist from Marion Merrell Dow, MDL 73,147EF, will be described at...

FIRST QUARTER LOSS AT ALLELIX

17 February 1992

Canadian biopharmaceutical concern Allelix has reported a loss of around C$300,000 ($254,790) for the first quarter ended November 30, 1991....

RISING HEALTH CARE COSTS IN SPAIN

17 February 1992

Family expenditure in Spain on medication has progressively fallen in recent years, and at the same time, the costs of...

AIDS TREATMENT FROM JOHNSON MATTHEY

17 February 1992

A new potential treatment for AIDS patients has been developed by the precious metals group of UK-based Johnson Matthey. As...

CHINESE DRUG PRODUCTION IN 1991

17 February 1992

Chinese pharmaceutical production was valued at 39.9 billion yuan ($7.4 billion) in 1991, reports the People's Daily, quoted in...

USTR INVITES COMMENTS ON INDIAN PATENT ACTION

17 February 1992

The US Trade Representative, Carla Hills, has intensified her country's pressure on India over the issue of intellectual property rights...

Showing 94761-94770 of 95353 articles